NantHealth, Inc. (NH): Price and Financial Metrics
GET POWR RATINGS... FREE!
NH POWR Grades
- Growth is the dimension where NH ranks best; there it ranks ahead of 74.53% of US stocks.
- The strongest trend for NH is in Momentum, which has been heading down over the past 31 weeks.
- NH's current lowest rank is in the Value metric (where it is better than 20.1% of US stocks).
NH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for NH is -0.54 -- better than only 5.07% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -1.94 for NantHealth Inc; that's greater than it is for only 4.74% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, NantHealth Inc is reporting a growth rate of 4,307.79%; that's higher than 99.63% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to NantHealth Inc are RFP, WTM, CINF, ITMR, and ITRN.
- Visit NH's SEC page to see the company's official filings. To visit the company's web site, go to nanthealth.com.
NH Valuation Summary
- NH's price/sales ratio is 3.2; this is 39.62% lower than that of the median Technology stock.
- NH's price/sales ratio has moved down 37.5 over the prior 62 months.
- Over the past 62 months, NH's price/sales ratio has gone down 37.5.
Below are key valuation metrics over time for NH.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| NH | 2019-11-01 | 0.8 | -2.6 | -0.4 | -1.7 |
| NH | 2019-06-14 | 0.7 | -3.9 | -0.3 | -1.5 |
| NH | 2019-05-28 | 0.7 | -3.8 | -0.3 | -1.5 |
| NH | 2018-12-27 | 0.6 | 1.1 | -0.3 | -1.5 |
| NH | 2018-04-09 | 3.9 | 1.7 | -1.9 | -2.9 |
| NH | 2017-01-06 | 23.8 | 2.8 | -14.0 | -14.1 |
NH Price Target
For more insight on analysts targets of NH, see our NH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $3.75 | Average Broker Recommendation | 1.25 (Strong Buy) |
NH Stock Price Chart Interactive Chart >
NH Price/Volume Stats
| Current price | $1.97 | 52-week high | $6.60 |
| Prev. close | $2.06 | 52-week low | $1.87 |
| Day low | $1.93 | Volume | 111,300 |
| Day high | $2.03 | Avg. volume | 374,556 |
| 50-day MA | $2.39 | Dividend yield | N/A |
| 200-day MA | $2.93 | Market Cap | 223.51M |
NantHealth, Inc. (NH) Company Bio
NantHealth Inc. operates as a healthcare cloud-based information technology company. The Company offers a clinical platform that provide actionable health information at the point of care for critical illnesses. The company was founded in 2007 and is based in Culver City, California.
Latest NH News From Around the Web
Below are the latest news stories about NantHealth Inc that investors may wish to consider to help them evaluate NH as an investment opportunity.
Where Do Hedge Funds Stand On NantHealth, Inc. (NH)?No summary available. |
NantHealth Consensus Indicates Potential 41.5% UpsideNantHealth with ticker code (NH) now have 2 analysts covering the stock with the consensus suggesting a rating of ''None''. The range between the high target price and low target price is between 4 and 3.5 calculating the average target price we see 3.75. Given that the stocks previous close was at 2.65 this now indicates there is a potential upside of 41.5%. The 50 day moving average now sits at 2.56 and the 200 moving average now moves to 3.24. The company has a market capitalisation of $303m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a softwa... |
NantHealth Consensus Indicates Potential 39.9% UpsideNantHealth with ticker code (NH) have now 2 analysts in total covering the stock. The consensus rating is ''None''. The range between the high target price and low target price is between 4 and 3.5 and has a mean target at 3.75. Given that the stocks previous close was at 2.68 this would imply there is a potential upside of 39.9%. There is a 50 day moving average of 2.54 and the 200 day MA is 3.22. The company has a market capitalisation of $304m. Company Website: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solutio... |
NantHealth Consensus Indicates Potential 51.8% UpsideNantHealth with ticker code (NH) have now 2 analysts in total covering the stock. The consensus rating is ''None''. The range between the high target price and low target price is between 4 and 3.5 with a mean TP of 3.75. Now with the previous closing price of 2.47 this would indicate that there is a potential upside of 51.8%. The day 50 moving average is 2.7 while the 200 day moving average is 3.19. The market capitalisation for the company is $285m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decisio... |
NantHealth Consensus Indicates Potential 57.6% UpsideNantHealth found using ticker (NH) have now 2 analysts covering the stock. The analyst consensus points to a rating of ''None''. The target price ranges between 4 and 3.5 calculating the mean target price we have 3.75. Given that the stocks previous close was at 2.38 this would imply there is a potential upside of 57.6%. The day 50 moving average is 2.81 and the 200 day moving average is 3.18. The company has a market cap of $255m. Company Website: /> [stock_market_widget type="chart" symbol="NH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] NantHealth, together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centraliz... |
NH Price Returns
| 1-mo | -21.83% |
| 3-mo | -24.52% |
| 6-mo | -53.32% |
| 1-year | -50.87% |
| 3-year | -37.26% |
| 5-year | -80.50% |
| YTD | -39.01% |
| 2020 | 213.59% |
| 2019 | 90.74% |
| 2018 | -82.30% |
| 2017 | -69.32% |
| 2016 | N/A |
Continue Researching NH
Want to do more research on NantHealth Inc's stock and its price? Try the links below:NantHealth Inc (NH) Stock Price | Nasdaq
NantHealth Inc (NH) Stock Quote, History and News - Yahoo Finance
NantHealth Inc (NH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...